Back to News
Market Impact: 0.3
Impact BioMedical Announces Reverse Stock Split To Advance Merger With Zoar Ltd.
Source: Nasdaq
M&A & RestructuringHealthcare & Biotech
Impact BioMedical will implement a 1-for-12.62 reverse stock split to facilitate its proposed merger with Zoar Ltd. The transaction is intended to create a combined company with expanded manufacturing and clinical-development capabilities, but the reverse split may signal capital-markets and listing-related pressures for existing shareholders.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
mildly negative
Sentiment Score
-0.25
Ticker Sentiment
IBO0.15
More News
- Wendy's shares jump 15% as Nelson Peltz's Trian offers $1.4 billion to buy burger chain
- Aker BP Q3 profit tops forecast on $870 million writedown reversal
- GE Vernova shares slip despite a beat-and-raise. What the sellers are getting wrong
- DoorDash Moves Earnings Date Forward Amid Instacart Deal Reports
- Nvidia's $12.9 billion Hugging Face deal draws DOJ scrutiny
- Peltz’s Trian Offers $1.4 Billion for Wendy’s, WSJ Reports